Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DNA Methylation in Malar Melasma and Its Change by Sunscreen, Retinoic Acid and Niacinamide.

NCT03392623 is registered in ClinicalTrials.gov with Universidad Autonoma de San Luis Potosí as lead sponsor.

NCT NCT03392623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03392623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DNA Methylation in Malar Melasma and Its Change by Sunscreen, Retinoic Acid and Niacinamide.
Lead sponsor
Universidad Autonoma de San Luis Potosí
Phase
Phase 1
Overall status
Completed
Start date
January 1, 2015
Completion date
December 1, 2016
Enrollment
28 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

melasma